Genzyme (SNY) Announces Receipt of FDA Breakthrough Designation for Olipudase Alfa

June 4, 2015 6:16 AM EDT Send to a Friend
Genzyme, a Sanofi (NYSE: SNY) company, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login